Related Experiment Video
Updated: Jun 17, 2026

Inducible and Reversible Dominant-negative (DN) Protein Inhibition
Published on: January 7, 2019
A heterozygous mutation in the third transmembrane domain causes a dominant-negative effect on signalling capability
Patrick Tarnow1, Anne Rediger, Harald Brumm
1Department of Pediatric Endocrinology, Charité, Campus Virchow-Klinikum - Universitatsmedizin Berlin, Berlin, Germany.
Background:
Heterozygous MC4R mutation is the most frequent cause of monogenic obesity. For most MC4R mutations a gene dosage effect seems to be the underlying mechanism. However, a dominant negative effect of a heterozygous MC4R mutation was recently identified, pointing to an additional mechanism of MC4R inactivation.
Methods:
The complete loss-of-function mutation (Ser136Phe), identified in a cohort of obese Austrian patients, was characterized for cell surface expression, signal transduction and ligand binding properties. Co-transfection studies tested for a dominant negative effect. Dimerization was investigated by a sandwich ELISA and by fluorescence resonance energy transfer (FRET) approach. Potential intramolecular interactions of Ser136 were studied by homologous receptor modelling based on the crystal structure of the beta2-adrenergic receptor.
Results:
The Ser136Phe mutation showed a dominant negative effect. The sandwich ELISA and FRET approach demonstrated dimerization of mutant and wild type receptor. Receptor modelling revealed an essential function of Ser136 at transmembrane helix 3 (TMH3) for establishing H-bonds between TMH2, TMH3, and TMH7. The mutation Ser136Phe most likely disrupts this network and leads to an incompetent helix-helix arrangement in the mutated receptor.
Conclusion:
Identification of dominant negative MC4R mutations is important to fully understand receptor function and to determine receptor regions that are involved in MC4R dimer activation.
Insights
A specific mutation in the melanocortin 4 receptor (MC4R) causes obesity through a dominant negative effect, disrupting receptor function. This finding reveals new insights into MC4R inactivation mechanisms and therapeutic targets for obesity.
Area of Science:
- Endocrinology
- Molecular Biology
- Genetics
Background:
- Heterozygous MC4R mutations are a primary cause of monogenic obesity.
- While gene dosage is a common mechanism, dominant negative effects offer an alternative explanation for MC4R inactivation.
Observation:
- The Ser136Phe mutation, found in obese patients, exhibits a dominant negative effect.
- This mutation leads to dimerization of mutant and wild-type MC4R receptors.
Findings:
- The Ser136Phe mutation disrupts crucial hydrogen bonds within the MC4R, affecting its structural integrity.
- Receptor modeling indicates Ser136 is vital for the helix-helix interactions necessary for MC4R function.
Implications:
- Understanding dominant negative MC4R mutations is key to comprehending MC4R function.
- This research identifies specific receptor regions involved in MC4R dimer activation, potentially leading to new therapeutic strategies for obesity.
Related Concept Videos
Incomplete Dominance
Lethal Alleles
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
The Ras Gene
Ras is a superfamily...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Epistasis Analysis
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
